H. A. Huang

The effect on sotrastaurin pharmacokinetics of strong CYP3A inhibition by ketoconazole.

J. Kovarik, A. Slade, H. A. Huang, 2009, British journal of clinical pharmacology.

Pharmacokinetics and Bioavailability of the Novel Rivastigmine Transdermal Patch Versus Rivastigmine Oral Solution in Healthy Elderly Subjects

B. Kiese, G. Sedek, G. Lefèvre, 2008, Journal of clinical pharmacology.

Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application

B. Kiese, G. Sedek, G. Lefèvre, 2007, Journal of clinical pharmacology.

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice‐daily Capsules in Alzheimer's Disease Patients

L. Ereshefsky, H. Schmidli, G. Sedek, 2008, Clinical pharmacology and therapeutics.

Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers*

S. Vaidyanathan, M. Bizot, W. Dole, 2008, Current medical research and opinion.